NCT05699629 Prospective Coronary Heart Disease Cohort
| NCT ID | NCT05699629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shandong First Medical University |
| Condition | Coronary Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2022-01-21 |
| Primary Completion | 2027-01-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2022-01-21 with a primary completion date of 2027-01-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Eligibility Criteria
Inclusion Criteria: * Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography. * Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects. Exclusion Criteria: * With malignant tumors, infectious diseases and advanced liver diseases. * Won't sign an inform consent.
Contact & Investigator
Tao Xu, Dr.
STUDY CHAIR
Shandong First Medical University
Frequently Asked Questions
Who can join the NCT05699629 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05699629 currently recruiting?
Yes, NCT05699629 is actively recruiting participants. Contact the research team at huangrong9277@163.com for enrollment information.
Where is the NCT05699629 trial being conducted?
This trial is being conducted at Jinan, China.
Who is sponsoring the NCT05699629 clinical trial?
NCT05699629 is sponsored by Shandong First Medical University. The principal investigator is Tao Xu, Dr. at Shandong First Medical University. The trial plans to enroll 50,000 participants.